NAKA - NASDAQ

Nakamoto Inc.

NAKA·NASDAQ

$4.77

-3.3%

Financial ServicesFinancial - Capital Markets

Kindly MD, Inc., a healthcare and healthcare data company, provides direct health care services to patients integrating prescription medicine and behavioral health services. The company offers specialty outpatient clinical services based on a subscription and fee-for-service basis to augment traditional healthcare. It provides evaluation and management services, including chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support, overdose education, peer support, limited urgent care, preventative medicine, travel, and hormone therapy; and data collection and research, and online and email campaign marketing services, as well as engages in the retail sale of health care products through clinics and online. Kindly MD, Inc. was formerly known as Utah Therapeutic Health Center, LLC and changed its name to Kindly MD, Inc. in March 2022. The company was incorporated in 2019 and is based in Salt Lake City, Utah.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$4.58B

EPS-0.2600

P/E Ratio-18.35

Earnings Date08/04/2026

naka

Total Liabilities and Equity

Last Annual Value

730.61M

3-Year CAGR

817%

5-Year CAGR

339%

10-Year CAGR

110%

Adjust for Inflation

Nakamoto Inc. Competitors Analysis of Total Liabilities and Equity

NAKA · NASDAQ

Company	Total Liabilities and Equity	CAGR 3Y	CAGR 5Y	CAGR 10Y
Nakamoto Inc. NASDAQ:NAKA	730.61M	772.7%	339.1%	N/A
Definitive Healthcare Corp. NASDAQ:DH	735.49M	-26.1%	-19.1%	N/A
Agilon Health, Inc. NYSE:AGL	1.27B	-9.9%	-4.3%	N/A
Allogene Therapeutics, Inc. NASDAQ:ALLO	415.90M	-13.5%	-16.9%	N/A
Kyverna Therapeutics, Inc. NASDAQ:KYTX	293.83M	57.5%	28.0%	N/A
LifeMD, Inc. NASDAQ:LFMD	70.41M	6.4%	7.1%	56.7%
908 Devices Inc. NASDAQ:MASS	190.07M	-2.2%	-6.1%	N/A
TruBridge, Inc. NASDAQ:TBRG	402.53M	-2.3%	1.0%	1.7%
Voyager Therapeutics, Inc. NASDAQ:VYGR	252.28M	-10.4%	5.4%	2.9%
Neumora Therapeutics, Inc. Common Stock NASDAQ:NMRA	191.05M	-27.3%	-14.9%	N/A
Lyell Immunopharma, Inc. NASDAQ:LYEL	340.05M	-23.2%	-21.3%	N/A

Nakamoto Inc. Fair Value Envelope

NAKA · NASDAQ

Our analysis suggests that NAKA has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $4.77, this represents a potential HIDDEN relative to our calculated worth for Nakamoto Inc..

HIDDEN

Intrinsic Value

Current Price: $4.77

Related Guides

Blog Categories

Continue your NAKA research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.